Biophytis Announces Promising Full Results From the SARA-INT Phase 2b Trial of…
Sarconeos (BIO101) at the highest dose (350 mg bid) showed a clinically meaningful improvement in the 400-Meter Walk Test (400MWT), the primary endpoint of the study, including in…